Skip to main content Start main content

Technology & Collaborative Platform

All
WhatsApp Image 20190604 at 94722 PM

BIO International Convention / BIO Digital

BIO Digital is the largest, most influential biotech meeting in the world offering our experts extensive exposure from targeted education sessions and specialty forums to partnering meetings with an average of over 1800 exhibitors and 15,500+ top tier biotech executives from 69 countries. RIO participates and showcases PolyU biotech research expertise at this yearly occasion, and explore collaborative opportunities with key industry players and research / academic institutes. Our faculty and researchers are welcome to join us as delegates and promote in person your technologies. Visit here to learn more. Enquiries PolyU red_05 rio.general@polyu.edu.hk PolyU red_06 +852 3400 2806

Overseas

Life Science & Biotechnology

2020_05_20-Press Release photos of peptides data storage for space exploration-26-2020_05_20 edit

Space Biology Experiment

Riding on the support and collaboration with China Aerospace Science and Technology Corporation, Space Biology Group, China Resources Life Sciences Group and various other research partners, PolyU is keen to develop forward-looking research projects for future space missions. PolyU has a strong research track record in space technology, with our researchers having been involved in a number of national and international space exploration projects since the 1990s. From participating in space biology experiment to the nation’s plan for space exploration to Mars, PolyU looks forward to further collaborate with various research partners to develop other forward-looking research projects for future space missions. May 2020 - PolyU Explores the Application of Peptides in Data Storage for Space Exploration in China’s Next-generation Manned Spacecraft ​ With the huge amount of digital data generated and recorded during space missions, the data storage devices currently used for this purpose reveal great limitations in terms of their data storage capacity and the durability of the retained data. To meet this challenge, a team of The Hong Kong Polytechnic University researchers has developed a novel technology for massive data management involving the use of peptides, which has been developed to optimise data storage for space exploration in China’s next-generation manned spacecraft in the new Long March-5B rocket. Compared with existing commercial data storage devices and other developing technologies such as DNA data storage, peptides offer a much higher storage density and longer storage duration – with the data still viable for sequencing even after millions of years when DNA would have already degraded. As such, this new technology has very great potential for handling the enormous amount of data generated during space missions. For details, please visit here. Nov 2019: PolyU Visited Space Biology Group to plan for research collaboration

Mainland China

Life Science & Biotechnology

PolyU joins the National Research Institute of Sun Yat-sen University as a council unit

PolyU joins the National Research Institute of Health and Medical Big Data of Sun Yat-sen University as a council unit Chinese Health Information and Big Data Association and Sun Yat-sen University have established the National Research Institute of Health and Medical Big Data of Sun Yat-sen University in the Guangdong-Hong Kong-Macao Greater Bay Area to step forward the innovative cooperation among Guangdong, Hong Kong and Macao, to build a platform to share health data resources for research and applications. PolyU as one of the Council members, was invited to attend the preparatory meeting for the establishment of the Council on 20 May, and the opening ceremony of the National Research Institute on 25 May, to jointly foster the development of research in health big data and application in the Greater Bay Area. For more details, please visit the website of Sun Yat-sen University December 2018 - "2018 Biotechnology Innovation in Greater Bay Area” Summit July 2018 - 2018 Biotech Summit “Biotech/Pharma, Life Science, and Medical Devices Development in Greater Bay Area - Opportunities and Roadmap to Success”

Mainland China

Greater Bay Area

Life Science & Biotechnology

8-7N4A6135

Joint Center for Immunotherapy

PolyU joins forces with Axis Therapeutics, a newly established joint venture by two global biopharmaceutical companies – Athenex, Inc. and Xiangxue Pharmaceutical, to foster the research and development of translational medicine by setting up a Joint Center for Immunotherapy. The Center is set to conduct collaborative research on cancer immunotherapy, with an aim to develop new cancer treatments. PolyU will provide full support for the research on novel technologies and genetics models to develop cancer immunotherapy technologies, and is committed in transferring pioneering research to real-life applications for the benefits of mankind.

Overseas

Mainland China

Life Science & Biotechnology

WARD0241_angle

PolyU - Fraunhofer-Gesellschaft - KIT Life Sciences and Engineering R&D Platform

PolyU joins forces with the Fraunhofer-Gesellschaft (Fraunhofer) and the Karlsruhe Institute of Technology (KIT), two leading research organisations in Germany, to drive collaborative applied research and technology development in the area of life sciences and engineering for the benefits of the global community. This collaboration will bring in significant innovations in chronic diseases, immunomodulation, traditional Chinese medicines, and translational medicine, and thus to bring about more translational deliverables to the society.

Overseas

Life Science & Biotechnology

NR2A7559_small_1

Biotechnology and Translational Medicine International Collaboration

Biotechnology and Translational Medicine International Collaboration among US · Guangdong - Hong Kong - Macau Greater Bay Area PolyU together with alliance partners from the Guangdong - Hong Kong - Macau Greater Bay Area including Sun Yat-sen University, Shenzhen University, and Macau University of Science and Technology, initiate the first biotechnology and translational medicine research platform with The State University of New York at Buffalo (SUNY Buffalo) and Roswell Park Comprehensive Cancer Center. This collaboration puts together expertise from the collaborating parties and their networks to foster more applied research in biotechnology, and bring cutting-edge innovations in the areas of cancer, genomics, translational medicine, and other related areas in biotechnology. NR2A7559_small_1 Thumnail-UB-Greater-Bay-Area_2018

Overseas

Mainland China

Life Science & Biotechnology

IMG_0732

Joint Institute of Translational Medicine

The Joint Institute of Translational Medicine was established by PolyU and the Banan District of Chongqing Municipal Government in April 2016. It aims to advance, in a collaborative manner, translational medicine researches in China through the effective transfer of research outputs into treatments for diseases. Taking advantages of the clinical and research strengths from both parties, the Institute will focus on projects such as anti-cancer drugs, medical imaging and genetic diagnosis and thus to develop related medication and diagnostic devices. It not only deepens international collaboration and industry partnerships in translational medicine, but is also expected to accelerate the offering of cost-effective medical solutions to patients.

Mainland China

Life Science & Biotechnology

DSC_8044

Respiratory Virus Research Foundation

Jointly established by PolyU and The University of Hong Kong in November 2015, the Respiratory Virus Research Foundation is to lead respiratory viral infection research and their corresponding translational research in Hong Kong. With the support of various donors, the teams from the two universities will collaborate actively with the industry to develop technologies and translate the results into clinically applicable products - products that will help the clinical management of patients with acute respiratory viral infections; from diagnostics, vaccines, vaccine adjuvants, to treatment. It is hoped that this collaboration will help to provide greater protection to the community in Hong Kong and beyond.

Mainland China

Life Science & Biotechnology

Your browser is not the latest version. If you continue to browse our website, Some pages may not function properly.

You are recommended to upgrade to a newer version or switch to a different browser. A list of the web browsers that we support can be found here